Mirela Tuzovic1,2, Pei-Tzu Wu1,2, Samuel Kianmahd1,2,3, Kim-Lien Nguyen1,2. 1. Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. 2. Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA. 3. School of Medicine, Stony Brook University, New York, NY, USA.
Abstract
OBJECTIVE: Anthracyclines are widely used to treat solid and hematologic malignancies, but are known to cause cardiotoxicity. As more childhood cancer survivors reach adulthood due to improvements in oncologic treatments, they become susceptible to late and progressive anthracycline-induced cardiotoxicity. Nonetheless, diagnostic criteria for early detection of cardiac dysfunction are not well defined in children, adolescent, and young adults (CAYA, ages 1-40 years). We present a natural history of the changes in myocardial deformation in CAYA patients after anthracycline therapy. METHODS: We performed a literature review search between 2001 and 2016 using PubMed with the following search terms: strain (or deformation), torsion (or twist), children (or adolescent or young adult), cardiotoxicity (or dysfunction), and anthracyclines (or doxorubicin). A total of 23 articles were reviewed. Fourteen articles were incorporated in the meta-analysis. RESULTS: Strain abnormalities are observed at both short-term and long-term follow-up. Global longitudinal strain (GLS) abnormalities are common during or early after chemotherapy, whereas changes in global circumferential strain (GCS) are more significant and consistent on long-term follow-up. Although global radial strain and torsional parameters are also often abnormal late after chemotherapy, there are few studies evaluating these parameters. CONCLUSION: There are significant abnormalities in GLS and GCS following anthracycline therapy acutely and late after treatment. The prognostic value of these strain abnormalities warrants further investigation.
OBJECTIVE: Anthracyclines are widely used to treat solid and hematologic malignancies, but are known to cause cardiotoxicity. As more childhood cancer survivors reach adulthood due to improvements in oncologic treatments, they become susceptible to late and progressive anthracycline-induced cardiotoxicity. Nonetheless, diagnostic criteria for early detection of cardiac dysfunction are not well defined in children, adolescent, and young adults (CAYA, ages 1-40 years). We present a natural history of the changes in myocardial deformation in CAYA patients after anthracycline therapy. METHODS: We performed a literature review search between 2001 and 2016 using PubMed with the following search terms: strain (or deformation), torsion (or twist), children (or adolescent or young adult), cardiotoxicity (or dysfunction), and anthracyclines (or doxorubicin). A total of 23 articles were reviewed. Fourteen articles were incorporated in the meta-analysis. RESULTS: Strain abnormalities are observed at both short-term and long-term follow-up. Global longitudinal strain (GLS) abnormalities are common during or early after chemotherapy, whereas changes in global circumferential strain (GCS) are more significant and consistent on long-term follow-up. Although global radial strain and torsional parameters are also often abnormal late after chemotherapy, there are few studies evaluating these parameters. CONCLUSION: There are significant abnormalities in GLS and GCS following anthracycline therapy acutely and late after treatment. The prognostic value of these strain abnormalities warrants further investigation.
Authors: Javier Ganame; Piet Claus; Benedicte Eyskens; Anne Uyttebroeck; Marleen Renard; Jan D'hooge; Marc Gewillig; Bart Bijnens; George R Sutherland; Luc Mertens Journal: Am J Cardiol Date: 2007-02-16 Impact factor: 2.778
Authors: Javier Ganame; Piet Claus; Anne Uyttebroeck; Marleen Renard; Jan D'hooge; Bart Bijnens; George R Sutherland; Bénédicte Eyskens; Luc Mertens Journal: J Am Soc Echocardiogr Date: 2007-07-02 Impact factor: 5.251
Authors: Susan C Gilchrist; Michael Roth; J Andrew Livingston; Michelle A T Hildebrandt; Eugenie S Kleinerman; Jose Banchs Journal: J Adolesc Young Adult Oncol Date: 2019-02-22 Impact factor: 2.223
Authors: Jan M Leerink; Esmée C de Baat; Remy Merkx; Elizabeth A M Feijen; Wouter E M Kok; Annelies M C Mavinkurve-Groothuis; Jacqueline Loonen; Helena J H van der Pal; Louise Bellersen; Chris L de Korte; Leontien C M Kremer; Elvira C van Dalen; Livia Kapusta Journal: J Cancer Surviv Date: 2021-03-27 Impact factor: 4.442
Authors: Gladys Olivera; Luis Sendra; María José Herrero; Pablo Berlanga; Pablo Gargallo; Yania Yáñez; Andrea Urtasun; Jaime Font de Mora; Victoria Castel; Adela Cañete; Salvador F Aliño Journal: Cancer Drug Resist Date: 2019-03-19
Authors: Rosaria Sofia; Veronica Melita; Antonio De Vita; Antonio Ruggiero; Alberto Romano; Giorgio Attinà; Lisa Birritella; Priscilla Lamendola; Antonella Lombardo; Gaetano Antonio Lanza; Angelica Bibiana Delogu Journal: Front Oncol Date: 2021-05-14 Impact factor: 6.244